health

Sort 2 diabetes drug Ozampic is dealing with scarcity after accepted by FDA as weight reduction drug Wegovy

Sort 2 diabetes drug Ozampic is dealing with scarcity after accepted by FDA as weight reduction drug Wegovy

Sort 2 diabetes drug Ozampic is dealing with scarcity after accepted by FDA as weight reduction drug Wegovy

Monday, January 16, 2023 1:57AM

Demand for a diabetes drug is on the rise, however the cause for that demand is being known as into query.

The drug semaglutide was initially marketed beneath the title Ozempic to handle sort 2 diabetes, however final 12 months, it was accepted by the FDA for use for weight reduction beneath the title Wegovy.

However now, the drug producer Novo Nordisk is struggling to fulfill demand, which medical doctors say is creating an issue for sort 2 diabetes sufferers.

RELATED: National Diabetes Awareness Month: Knowing signs and symptoms

“Our sufferers with diabetes are struggling simply to get their drugs to regulate their blood sugars and so we’re having to substitute different drugs, improve their insulin necessities. Individuals are gaining weight again from not being on these drugs and so it truly is changing into an issue for our sufferers which are coping with sort 2 diabetes. However then once more, there’s an epidemic of weight problems, as properly and we have to deal with the weight problems to stop the diabetes within the first place,” stated Dr. Disha Narang.

In line with the CDC, greater than 37 million Individuals have diabetes 90% to 95% of them have sort 2 diabetes.


#Sort #diabetes #drug #Ozampic #dealing with #scarcity #accepted #FDA #weight #loss #drug #Wegovy

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
asas-techno.com